Free provider profile
KATHARINE PARKER, DO
MINNEAPOLIS, MN
Find similar providers: Family Medicine, Addiction Medicine in MINNEAPOLIS, MN
Practice contact details
Source: CMS NPPES · published practice information
Practice phone
612-273-6099
Fax
612-273-6461
Practice address
606 24TH AVE S STE 602, MINNEAPOLIS, MN, 55454
- Registry updated
- 2025-04-25
- NPI issued
- 2013-06-16
- RepVector retrieved
- 11/22/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Specialties & registration
CMS NPPES taxonomy classifications · not verification of certification or services offered
Family Medicine, Addiction Medicine
207QA0401X
PrimaryFamily Medicine
207Q00000X
2 registered practice locations · A registry listing does not establish active practice, referral relationships or insurance participation.
Need more providers like KATHARINE PARKER?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What KATHARINE PARKER prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Buprenorphine-Naloxone
- Gabapentin
- Buprenorphine Hcl
- Topiramate
- Trazodone Hcl
See all family medicine physicians in MN who bill Medicare →
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
478
Medicare patients
50
Part D drug cost
$54,027
Brand-name share
4.8%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl) | 139 | $29,516 |
| Suboxone (Buprenorphine Hcl/Naloxone Hcl) | 11 | $9,659 |
| Acamprosate Calcium (Acamprosate Calcium) | 20 | $3,194 |
| Gabapentin (Gabapentin) | 51 | $1,403 |
| Buprenorphine Hcl (Buprenorphine Hcl) | 49 | $910 |
| Naltrexone Hcl (Naltrexone Hcl) | 16 | $688 |
| Topiramate (Topiramate) | 28 | $455 |
| Trazodone Hcl (Trazodone Hcl) | 28 | $300 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across MN — which companies pay providers there.
Open Payments page for this provider
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
